NovoCure Limited - Ordinary Shares (NVCR)
NovoCure Limited - Ordinary Shares (NVCR)
$81.74 USD
Updated Sep 20 11:40am
Add NVCR to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 216 in Medical - Pharmaceuticals
See all “A” rated Strong Buy stocks
NVCR Stock Chart More Charts
NVCR Price/Volume Stats
| Current price | $81.74 |
| Prev. close | $79.96 |
| Day low | $79.35 |
| Day high | $81.74 |
| 50-day MA | $82.82 |
| 200-day MA | $56.94 |
| 52-week high | $98.70 |
| 52-week low | $26.02 |
| Volume | 328,524 |
| Avg. volume | 735,522 |
| Dividend yield | N/A |
| Market Cap | 8.02B |
NovoCure Limited - Ordinary Shares (NVCR) Company Bio
NovoCure Limited is a commercial stage oncology company which develops treatment for solid tumor cancers therapy called the tumor treating fields. The company was founded in 2000 and is based in Saint Helier, Channel Islands.
Top Stories View All
Best & Worst Performing Stock Industries for September 19, 2019
Best & Worst Performing Small Cap Stocks for September 19, 2019
Best & Worst Performing Mid Cap Stocks for September 19, 2019
Best & Worst Performing Large Cap Stocks for September 19, 2019
Best & Worst Performing Mega Cap Stocks for September 19, 2019
View All Top Stories
Loading social stream, please wait...